0
ARTICLE |

Exacerbation of Hyperthyroidism by Methimazole During Iodide Therapy

THADDEUS E. PROUT, M.D.; SAMUEL P. ASPER, M.D.
AMA Arch Intern Med. 1958;101(2):364-368. doi:10.1001/archinte.1958.00260140196029.
Text Size: A A A
Published online

The care of patients with hyperthyroidism has been facilitated by the use of compounds which block the production of thyroid hormone. Early reports on the clinical use of such antithyroid drugs state that patients with thyrotoxicosis who were being treated with iodide frequently had an exacerbation of hyperthyroidism upon initiation of therapy with an antithyroid drug.1,2 Although many other effects of these drugs on the thyroid have been studied,3,4 this phenomenon has not been adequately explained. Further observations on the increase in the severity of symptoms which occur under these circumstances are recorded in this paper. Four patients with hyperthyroidism have been given methimazole during potassium iodide therapy. The effects of these medications on the symptoms, the values of the basal metabolic rate, and the levels of the butanol-extractable iodine of the blood in these patients are reported.

Method  The four patients in this study were women, ranging

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs